Biotechnology

Tetra Bio-Pharma Completes Major Milestone for COVID-19 Therapeutic

December 2, 2020 6:30 AM

PATHWAY NOW CLEARED FOR HUMAN TRIALS OTTAWA, ON / ACCESSWIRE / December 2, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced it has completed Investigational New Drug (IND) -enabling toxicology, clearing the way for human clinical trials for its novel drug candidate ARDS-003. Acute Respiratory Distress Syndrome (ARDS) is a...

Read more

Patriot Scientific Corporation Announces Name Change to "Mosaic ImmunoEngineering Inc.", Stock Symbol Change and Reverse Stock Split

December 1, 2020 4:20 PM

NOVATO, CA / ACCESSWIRE / December 1, 2020 / Patriot Scientific Corporation ("Patriot") (OTC PINK:PTSC) announced today that it has changed its name to "Mosaic ImmunoEngineering Inc.", (the "Company" or "Mosaic") effective immediately. In addition, the Company will change its stock symbol on the OTC Market to "CPMV" as described below and will effect a reverse stock split at a ratio of 1-for-500 (the "Reverse Stock Split") anticipated to be...

Read more

Rising Biosciences, Inc. Expects to Surpass Milestone Sales Benchmark for 2020

December 1, 2020 1:15 PM

SANDUSKY, OH / ACCESSWIRE / December 1, 2020 / Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall reported that the company is expecting to achieve and surpass a milestone sales benchmark in the fiscal year 2020. "We were extraordinarily pleased with our sales results in the third quarter, a second consecutive record quarter for us", said Hall. "We're now poised to hit and break the $1 million sales number for the year! Given the...

Read more

Applied UV Announces U.S. Patent to be Issued for a System to Neutralize Pathogens on Tactile Surfaces, Including Bank ATMs

December 1, 2020 8:30 AM

Sterilumen's patent Application for a UV Light sanitizing solution designed to be retrofitted to Bank ATMs to automatically disinfect surfaces on an ATM machine, including a keyboard, touchscreen, credit card reader between uses has been allowed by the U.S. Patent and Trademark Office MOUNT VERNON, NY / ACCESSWIRE / December 1, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company...

Read more

Hancock Jaffe Announces One Year Follow-up Data on Tenth VenoValve Patient

December 1, 2020 8:30 AM

Patient Shows Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / December 1, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the tenth VenoValve patient in HJLI's first-in-human, clinical study has successfully reached the one-year milestone. Patient 10's chronic venous insufficiency ("CVI") has dramatically improved when...

Read more

Havn Life Attracts International Drug Science and Policy Expert, Joins UK Policy Reform Group

December 1, 2020 8:00 AM

Havn Life Has Joined the UK-Based Conservative Drug Policy Reform Group (CDPRG), Group Organized to Benefit Drug Policy-Making The Havn Life Advisory Board Adds Mr. King, a Vocal Advocate for Drug Policy Reform and Research VANCOUVER, BC / ACCESSWIRE / December 1, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company focused on unlocking human potential using evidence-informed...

Read more

Lexaria’s Patented Technology Significantly Enhances Oral Delivery of Antiviral Drugs

December 1, 2020 6:30 AM

Demonstrates Improved Delivery of Two Classes of Drugs in Use Against HIV/AIDS and under investigation Against SARS-CoV-2/COVID-19 KELOWNA, BC / ACCESSWIRE / December 1, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announces that its DehydraTECHTM technology significantly improved delivery in study animals of representative drugs from two classes of...

Read more

American CryoStem Announces Patient Recruitment and Additional Sub-Investigator for its Post-Concussion Syndrome (PCS) Phase I Clinical Trial

December 1, 2020 6:00 AM

EATONTOWN, NJ / ACCESSWIRE / December 1, 2020 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies announced today that it has commenced recruiting subjects for its IND Phase I Clinical Trial and added an additional sub-investigator to the ATCELL™ Clinical Trial team. The Company's autologous mesenchymal stem cell infusion therapy...

Read more

Molecular Partners to Participate in the Evercore ISI 3rd Annual HealthCONx Conference

November 30, 2020 11:45 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / November 30, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced that Dr. Patrick Amstutz, CEO of Molecular Partners, will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020 at 3:55 - 4:25 PM Eastern Time (9:55...

Read more

Edesa Biotech Enrolls First Patient in COVID-19 Study

November 30, 2020 7:30 AM

TORONTO, ON / ACCESSWIRE / November 30, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today announced that the first patient has been enrolled in a Phase 2/Phase3 clinical trial evaluating the company's investigational drug, EB05, as a therapy for hospitalized COVID-19 patients. EB05 is a clinical-stage monoclonal antibody that Edesa believes could regulate the overactive and dysfunctional immune...

Read more

Binovi Announces Debt Settlement

November 27, 2020 8:00 PM

TORONTO, ON AND NEW YORK, NY / ACCESSWIRE / November 27, 2020 / Binovi Technologies Corp., (Binovi) (TSXV:VISN)(OTCQB:BNVIF), a leader is neuro-vision performance technology, announces that, subject to the approval of the TSX Venture Exchange, it intends to settle $214,088.70 in outstanding indebtedness to an arms-length party through the issuance of an aggregate of 1,223,364 common shares at a price of $ 0.175 per share. The shares issued under...

Read more

Hancock Jaffe Announces Reverse Stock Split

November 27, 2020 8:30 AM

IRVINE, CA / ACCESSWIRE / November 27, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1 for 25 (the "Reverse Stock Split"). The Reverse Stock Split will become effective at 12:01 a.m. Eastern time on November 30, 2020 and the Company's...

Read more

Richard Sorgnard Identifies How Technology Can Address Neuropathic Disorders

November 25, 2020 1:50 PM

Technology is Helping Patients Improve Pain and Overcome Neuropathic Disorders, Explains Richard Sorgnard LAS VEGAS, NV / ACCESSWIRE / November 25, 2020 / Technology in the medical industry has been used for decades. However, it is mostly used to aid doctors. Now, electric signal generation technology is being used to aid patients. Richard Sorgnard has developed a number of tools to help with neuropathic disorders. Richard Sorgnard is...

Read more

Havn Life Sciences Announces $5.46 Million Warrant Exercise

November 24, 2020 8:00 AM

VANCOUVER, BC / ACCESSWIRE / November 24, 2020 / Havn Life Sciences Inc. (CNSX:HAVN)(FSE:5NP) (the "Company" or "Havn Life") is pleased to announce that 10,927,856 common share purchase warrants ("Warrants") have been exercised ("Exercise"), resulting in proceeds to the Company of $5.46 million. The Warrants had originally been issued by the Company pursuant to a private placement that closed on June 5, 2020 and were subject to an accelerated...

Read more

Midatech Pharma PLC Announces MTX110 presented at 2020 Annual SNO Conference

November 24, 2020 2:00 AM

ABINGDON, OXFORDSHIRE / ACCESSWIRE / November 24, 2020 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to note that the latest research on MTX110 was presented by its collaborators at the recent annual meeting of the Society of Neuro-Oncology (SNO2020 Virtual Conference). Links to the Abstracts and Posters are provided...

Read more

HF Enterprises Inc. Announces Pricing of Initial Public Offering

November 23, 2020 10:40 PM

BETHESDA, MD / ACCESSWIRE / November 23, 2020 / HF Enterprises Inc. (NASDAQ:HFEN)(the "Company"), a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology and biohealth activities, today announced the pricing of its initial public offering of 2,160,000 shares of its common stock at a public offering price of $7.00 per share for gross proceeds of $15,120,000 before...

Read more

Apollo Endosurgery to Present at Piper Sandler Healthcare Conference

November 23, 2020 11:40 AM

AUSTIN, TX / ACCESSWIRE / November 23, 2020 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate in the 32nd Annual Piper Sandler Healthcare Conference. December 1-2, 2020 32nd Annual Piper Sandler Healthcare Conference Apollo management will participate in virtual one on one...

Read more

Hillstream BioPharma’s HSB-888 Receives Rare Pediatric Disease Designation and Orphan Drug Designation for Osteosarcoma

November 23, 2020 9:45 AM

Osteosarcoma remains the most common primary pediatric bone malignancy mostly occurring in adolescents for which treatment has remained essentially unchanged for the past three decades Osteosarcoma is a highly-aggressive tumor with metastatic disease either at diagnosis or at the time of recurrence portending a poor prognosis with five-year survival rate survival below 30% HSB-888 could be more efficacious, safer and a more tolerable...

Read more

Hancock Jaffe's VenoValve(R) Results Featured in Journal of Vascular Surgery Venous and Lymphatic Disorders

November 23, 2020 8:30 AM

Preliminary First-in-Human Study Results Published in Peer-Reviewed Journal IRVINE, CA / ACCESSWIRE / November 23, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Journal of Vascular Surgery Venous and Lymphatic Disorders, published a paper featuring interim results from the VenoValve first-in-human trial. The article entitled "Human Trial...

Read more

MedTechVIP Launches First Virtual and In-Person Event "MedTechVIP in Middleburg"

November 23, 2020 8:00 AM

The First MedTechVIP Family Office Event Designed to Educate, Inspire, and Connect Investors with Biodesign Innovations - A Meeting Where Clinical Impact Meets Economic Returns MIDDLEBURG, VA / ACCESSWIRE / November 23, 2020 / MedTechVIP is pleased to announce the first in an event series, "MedTechVIP in Middleburg ", an in-person and virtual gathering dedicated to highlighting Biodesign as an asset class. The event is geared as an...

Read more